Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Behar

Showing results (221-230 of 373) with videos related to

Pageof 38
Sort By:
The Journal of Experimental Medicine|October 29, 2008
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathMinjian Chen, Maziar Divangahi, Huixian Gan, et al.
Journal of Cardiovascular Electrophysiology|July 9, 2020
Tracking the motion of intracardiac structures aids the development of future leadless pacing systemsOrod Razeghi, Marina Strocchi, Angela Lee, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1989
Impact of somatic mutation on the S107(T15) heavy-chain V region of antibodies reactive with self and nonselfS M Behar, N C Chien, S Corbet, et al.
Journal of Cardiovascular Electrophysiology|October 10, 2023
Cost-effectiveness analysis of leadless cardiac resynchronization therapyNadeev Wijesuriya, Vishal Mehta, Felicity De Vere, et al.
Plos Pathogens|March 12, 2016
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis InfectionPushpa Jayaraman, Miye K Jacques, Chen Zhu, et al.
Cell Reports|June 4, 2026
NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infectionLinh K Pham, Maritza M Cervantes, Pamelia N Lim, et al.
Human Genetics|July 17, 2010
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneShay Tzur, Saharon Rosset, Revital Shemer, et al.
Clinical Trials and Regulatory Science in Cardiology|February 5, 2016
The impact of beat-to-beat variability in optimising the acute hemodynamic response in cardiac resynchronisation therapySteven Niederer, Cameron Walker, Andrew Crozier, et al.
Scientific Reports|November 8, 2016
IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infectionMatthew G Booty, Palmira Barreira-Silva, Stephen M Carpenter, et al.
International Journal of Cardiology. Heart & Vasculature|May 12, 2018
The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapyTom Jackson, Sana Amraoui, Manav Sohal, et al.
Pageof 38

Showing results (221-230 of 373) with videos related to

Sort By:
Pageof 38
The Journal of Experimental Medicine|October 29, 2008
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathMinjian Chen, Maziar Divangahi, Huixian Gan, et al.
Journal of Cardiovascular Electrophysiology|July 9, 2020
Tracking the motion of intracardiac structures aids the development of future leadless pacing systemsOrod Razeghi, Marina Strocchi, Angela Lee, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1989
Impact of somatic mutation on the S107(T15) heavy-chain V region of antibodies reactive with self and nonselfS M Behar, N C Chien, S Corbet, et al.
Journal of Cardiovascular Electrophysiology|October 10, 2023
Cost-effectiveness analysis of leadless cardiac resynchronization therapyNadeev Wijesuriya, Vishal Mehta, Felicity De Vere, et al.
Plos Pathogens|March 12, 2016
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis InfectionPushpa Jayaraman, Miye K Jacques, Chen Zhu, et al.
Cell Reports|June 4, 2026
NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infectionLinh K Pham, Maritza M Cervantes, Pamelia N Lim, et al.
Human Genetics|July 17, 2010
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneShay Tzur, Saharon Rosset, Revital Shemer, et al.
Clinical Trials and Regulatory Science in Cardiology|February 5, 2016
The impact of beat-to-beat variability in optimising the acute hemodynamic response in cardiac resynchronisation therapySteven Niederer, Cameron Walker, Andrew Crozier, et al.
Scientific Reports|November 8, 2016
IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infectionMatthew G Booty, Palmira Barreira-Silva, Stephen M Carpenter, et al.
International Journal of Cardiology. Heart & Vasculature|May 12, 2018
The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapyTom Jackson, Sana Amraoui, Manav Sohal, et al.
Pageof 38